Trial to test mild hyperbaric oxygen therapy during active treatment for aggressive brain cancer

Trial to test mild hyperbaric oxygen therapy during active treatment for aggressive brain cancer

LISMORE, Australia, March 16, 2026 /PRNewswire/ -- Australian researchers from Southern Cross University (SCU) and the Melbourne Integrative Oncology Group (MIOG) will launch a clinical study investigating whether hyperbaric oxygen therapy (HBOT)...

Alzheimer's Association Statement on Oral Semaglutide Phase 3 Topline Data Release

Alzheimer's Association Statement on Oral Semaglutide Phase 3 Topline Data Release

- Results Underscore Need for Continued Research and Diverse Treatment Pipeline CHICAGO, Nov. 24, 2025 /PRNewswire/ -- The Alzheimer's Association is disappointed that the evoke and evoke+ clinical trials did not demonstrate a statistically...

First Graphene Limited Announces Cement & Concrete Segment Update

First Graphene Limited Announces Cement & Concrete Segment Update

Highlights Production of 600 tonnes of low carbon PureGRAPH® enhanced cement to go ahead in December targeting several client applications Concrete roof tiles containing PureGRAPH® enhanced cement to be trialed by specialist precast concrete...

menu
menu